Report cover image

Rare Cell Isolation Market Size, Share & Trends Analysis Report By Product (Reagents & Kits, Instrument), By Cell Type (Circulating Tumor Cells, Stem Cells, Rare Immune Cells, Fetal Cells), By Technology, By Region, And Segment Forecasts, 2025 - 2033

Publisher Grand View Research
Published Oct 31, 2025
Length 120 Pages
SKU # GV20575232

Description

Rare Cell Isolation Market Summary

The global rare cell isolation market size was valued at USD 2.02 billion in 2024 and is projected to reach USD 5.09 billion by 2033, growing at a CAGR of 10.85% from 2025 to 2033. The rare cell isolation market has been experiencing significant growth, driven by advancements in biotechnology and the increasing need for precision medicine.

Rare cells, which include circulating tumor cells (CTCs), stem cells, and fetal cells, play crucial roles in early disease detection, treatment monitoring, and personalized therapy.

Global Rare Cell Isolation Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global rare cell isolation market report based on product, cell type, technology, and region:
  • Products Outlook (Revenue, USD Million, 2021 - 2033)
  • Reagent & Kits
  • Instrument
  • Cell Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Circulating Tumor Cells
  • Stem Cells
  • Fetal Cells
  • Rare Immune Cells
  • Circulating Endothelial Cells
  • Other Rare Cell Types
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Magnetic Bead Separation
  • Fluorescence-Activated Cell Sorting
  • Microfluidics-based techniques
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

120 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Products Segment
1.2.2. Cell Type Segment
1.2.3. Technology Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Rare cell isolation market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising prevalence of chronic and rare diseases
3.2.1.2. Technological advancement and innovation in cell isolation
3.2.2. Market restraint analysis
3.2.2.1. Strict regulations and compliances for cell separation
3.3. Rare Cell Isolation Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
Chapter 4. Rare Cell Isolation Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Rare Cell Isolation Market Products Movement Analysis
4.3. Global Rare Cell Isolation Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.4. Reagent & Kits
4.4.1. Reagent & kits market estimates and forecasts 2021 to 2033 (USD Million)
4.5. Instrument
4.5.1. Instrument market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. Rare Cell Isolation Market: Cell Type Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Rare Cell Isolation Market Application Movement Analysis
5.3. Global Rare Cell Isolation Market Size & Trend Analysis, by cell type, 2021 to 2033 (USD Million)
5.4. Circulating Tumor Cells
5.4.1. Circulating tumor cells market estimates and forecasts 2021 to 2033 (USD Million)
5.5. Stem Cells
5.5.1. Stem cells market estimates and forecasts 2021 to 2033 (USD Million)
5.6. Fetal Cells
5.6.1. Fetal cells market estimates and forecasts 2021 to 2033 (USD Million)
5.7. Rare Immune Cells
5.7.1. Rare immune cells market estimates and forecasts 2021 to 2033 (USD Million)
5.8. Circulating Endothelial Cells
5.8.1. Circulating endothelial cells market estimates and forecasts 2021 to 2033 (USD Million)
5.9. Other Rare Cell Types
5.9.1. Other rare cell types market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Rare cell isolation market: Technology Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Rare Cell Isolation Market Technology Movement Analysis
6.3. Global Rare Cell Isolation Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
6.4. Microfluidics-Based Techniques
6.4.1. Microfluidics-based techniques market estimates and forecasts 2021 to 2033 (USD Million)
6.5. Fluorescence-Activated Cell Sorting
6.5.1. Fluorescence-activated cell sorting market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. Rare cell isolation market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2024 & 2033
7.2. Regional Market Dashboard
7.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
7.4. North America
7.4.1. U.S.
7.4.1.1. Key country dynamics
7.4.1.2. Competitive scenario
7.4.1.3. Regulatory framework
7.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
7.4.2. Canada
7.4.2.1. Key country dynamics
7.4.2.2. Competitive scenario
7.4.2.3. Regulatory framework
7.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
7.4.3. Mexico
7.4.3.1. Key country dynamics
7.4.3.2. Competitive scenario
7.4.3.3. Regulatory framework
7.4.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
7.5. Europe
7.5.1. UK
7.5.1.1. Key country dynamics
7.5.1.2. Competitive scenario
7.5.1.3. Regulatory framework
7.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
7.5.2. Germany
7.5.2.1. Key country dynamics
7.5.2.2. Competitive scenario
7.5.2.3. Regulatory framework
7.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
7.5.3. France
7.5.3.1. Key country dynamics
7.5.3.2. Competitive scenario
7.5.3.3. Regulatory framework
7.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
7.5.4. Italy
7.5.4.1. Key country dynamics
7.5.4.2. Competitive scenario
7.5.4.3. Regulatory framework
7.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
7.5.5. Spain
7.5.5.1. Key country dynamics
7.5.5.2. Competitive scenario
7.5.5.3. Regulatory framework
7.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
7.5.6. Denmark
7.5.6.1. Key country dynamics
7.5.6.2. Competitive scenario
7.5.6.3. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
7.5.7. Sweden
7.5.7.1. Key country dynamics
7.5.7.2. Competitive scenario
7.5.7.3. Regulatory framework
7.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
7.5.8. Norway
7.5.8.1. Key country dynamics
7.5.8.2. Competitive scenario
7.5.8.3. Regulatory framework
7.5.8.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
7.6. Asia Pacific
7.6.1. Japan
7.6.1.1. Key country dynamics
7.6.1.2. Competitive scenario
7.6.1.3. Regulatory framework
7.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
7.6.2. China
7.6.2.1. Key country dynamics
7.6.2.2. Competitive scenario
7.6.2.3. Regulatory framework
7.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
7.6.3. India
7.6.3.1. Key country dynamics
7.6.3.2. Competitive scenario
7.6.3.3. Regulatory framework
7.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
7.6.4. Australia
7.6.4.1. Key country dynamics
7.6.4.2. Competitive scenario
7.6.4.3. Regulatory framework
7.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
7.6.5. South Korea
7.6.5.1. Key country dynamics
7.6.5.2. Competitive scenario
7.6.5.3. Regulatory framework
7.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
7.6.6. Thailand
7.6.6.1. Key country dynamics
7.6.6.2. Competitive scenario
7.6.6.3. Regulatory framework
7.6.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
7.7. Latin America
7.7.1. Brazil
7.7.1.1. Key country dynamics
7.7.1.2. Competitive scenario
7.7.1.3. Regulatory framework
7.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
7.7.2. Argentina
7.7.2.1. Key country dynamics
7.7.2.2. Competitive scenario
7.7.2.3. Regulatory framework
7.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
7.8. MEA
7.8.1. South Africa
7.8.1.1. Key country dynamics
7.8.1.2. Competitive scenario
7.8.1.3. Regulatory framework
7.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
7.8.2. Saudi Arabia
7.8.2.1. Key country dynamics
7.8.2.2. Competitive scenario
7.8.2.3. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
7.8.3. UAE
7.8.3.1. Key country dynamics
7.8.3.2. Competitive scenario
7.8.3.3. Regulatory framework
7.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
7.8.4. Kuwait
7.8.4.1. Key country dynamics
7.8.4.2. Competitive scenario
7.8.4.3. Regulatory framework
7.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2024
8.4. Company Profiles/Listing
8.4.1. Miltenyi Biotec
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Thermo Fisher Scientific, Inc.
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Danaher
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. QIAGEN N.V.
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Bio-techne
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. STEMCELL Technologies
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. CELLENION
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. RareCyte
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Illumina, Inc.
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. Bio-Rad Laboratories, Inc.
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us